Comment on: Unresponsiveness to AmBisome in some Sudanese patients with kala-azar.
de Górgolas
Miguel
M
D000666:Amphotericin B / Q000627:therapeutic use*; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007898:Leishmaniasis, Visceral / Q000188:drug therapy*; D017211:Treatment Failure
D000981:Antiprotozoal Agents; C068538:liposomal amphotericin B; D000666:Amphotericin B